Literature DB >> 24710031

Arsonists and firefighters: the perpetual inflammatory civil war for survival.

Joel S Karliner1.   

Abstract

Entities:  

Keywords:  Editorials; atherosclerosis; cholesterol; fingolimod; glycosphingolipids; hydroxymethylglutaryl-CoA reductase inhibitors; sphingosine

Mesh：

Substances：

Year:  2014        PMID： 24710031      PMCID： PMC4061904          DOI： 10.1161/CIRCULATIONAHA.114.010006

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  19 in total

1.  THE SEPARATION OF NEUTRAL BLOOD-SERUM GLYCOLIPIDS BY THIN-LAYER CHROMATOGRAPHY.

Authors:  E SVENNERHOLM; L SVENNERHOLM
Journal:  Biochim Biophys Acta       Date:  1963-08-27

Review 2.  Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance.

Authors:  Pertti J Neuvonen; Mikko Niemi; Janne T Backman
Journal:  Clin Pharmacol Ther       Date:  2006-12       Impact factor: 6.875

Review 3.  Statins are diabetogenic--myth or reality?

Authors:  Naveed Sattar; Marja-Riitta Taskinen
Journal:  Atheroscler Suppl       Date:  2012-07-19       Impact factor: 3.235

4.  The immunosuppressant FTY720 prolongs survival in a mouse model of diet-induced coronary atherosclerosis and myocardial infarction.

Authors:  Guanying Wang; Roy Y Kim; Isabella Imhof; Norman Honbo; Fu Sang Luk; Kang Li; Nikit Kumar; Bo-Qing Zhu; Delphine Eberlé; Daniel Ching; Joel S Karliner; Robert L Raffai
Journal:  J Cardiovasc Pharmacol       Date:  2014-02       Impact factor: 3.105

5.  FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Jerzy-Roch Nofer; Martine Bot; Martin Brodde; Paul J Taylor; Paul Salm; Volker Brinkmann; Theo van Berkel; Gerd Assmann; Erik A L Biessen
Journal:  Circulation       Date:  2007-01-22       Impact factor: 29.690

6.  Glycosphingolipid accumulation inhibits cholesterol efflux via the ABCA1/apolipoprotein A-I pathway: 1-phenyl-2-decanoylamino-3-morpholino-1-propanol is a novel cholesterol efflux accelerator.

Authors:  Elias N Glaros; Woojin Scott Kim; Carmel M Quinn; Jenny Wong; Ingrid Gelissen; Wendy Jessup; Brett Garner
Journal:  J Biol Chem       Date:  2005-05-11       Impact factor: 5.157

7.  The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Petra Keul; Markus Tölle; Susann Lucke; Karin von Wnuck Lipinski; Gerd Heusch; Mirjam Schuchardt; Markus van der Giet; Bodo Levkau
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-12-07       Impact factor: 8.311

Review 8.  Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials.

Authors:  Huseyin Naci; Jasper J Brugts; Rachael Fleurence; Bernice Tsoi; Harleen Toor; A E Ades
Journal:  Eur J Prev Cardiol       Date:  2013-02-27       Impact factor: 7.804

9.  Inflammation and atherosclerosis: disease modulating therapies.

Authors:  Mahesh J Patel; Michael A Blazing
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-12

10.  Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.

Authors:  Florence Bietrix; Elisa Lombardo; Cindy P A A van Roomen; Roelof Ottenhoff; Mariska Vos; Patrick C N Rensen; Arthur J Verhoeven; Johannes M Aerts; Albert K Groen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-18       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.